Inactive Instrument

Press Releases Natco Pharma Ltd. NSE India S.E.

Equities

INE987B01018

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

Apr. 09	Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	MT
Mar. 27	NATCO Pharma Limited Announces Board Appointments	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid, in the U.S	23-03-10	AQ
The Doctrine Of Equivalents In Patent Law: An Analysis Of The FMC Corporation vs Natco Pharma Limited Judgment	23-02-09	AQ
Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia	22-08-24	AQ
NATCO records INR 918.9 Crore consolidated revenue and INR 320.4 Crore of profit, after tax, for the First Quarter, FY2022-23	22-08-10	AQ
NATCO Pharma : Press Release	22-07-25	PU
NATCO Announces Launch of First Generic Version of Nexavar (Sorafenib) Tablets in the U.S. Market	22-06-02	AQ
NATCO records INR 2043.8 Crore consolidated revenue and INR 170.0 Crore of profit, after tax, for the year ended March 31' 2022	22-05-31	AQ
Natco Pharma - Edelweiss Securities invites you to Natco Pharma Q4 FY22 Earnings call	22-05-26	AQ
NATCO Announces Launch of the First Generic Version of Revlimid (Lenalidomide capsules), in the U.S. market	22-03-08	AQ
NATCO Pharma : Newspaper Advertisements	22-02-23	PU
NATCO Pharma : ESOP/ESOS/ESPS	22-01-28	PU
NATCO announces License Agreement with the Medicines Patent Pool	22-01-21	AQ
NATCO Pharma Limited has been awarded Corporate Governance Award07 January 2022	22-01-10	AQ
NATCO Pharma receives approval for Molnupiravir Capsules 200 mg for the treatment of Covid-19 in India	21-12-29	AQ
Natco Pharma : launches Everolimus tablets 10 mg in US market	21-10-04	AQ
NATCO Pharma : receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA ) ANDA in the US market	21-04-13	AQ
NATCO Pharma : forays into Pheromone based technology for Integrated Pest Management	21-03-16	AQ
NATCO Pharma : launches Brivaracetam tablets, in India, for treatment of epilepsy	21-03-01	AQ
NATCO Pharma : receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences Division	21-02-08	AQ
NATCO Pharma : launches anti blood clot tablet Rivaroxaban in India	20-12-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Natco Pharma Ltd. NSE India S.E.

Equities

INE987B01018

Press Releases

Filters